Stephen G. Dilly
2014 - Aimmune Therapeutics
In 2014, Stephen G. Dilly earned a total compensation of $469.7K as Chief Executive Officer at Aimmune Therapeutics.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Option Awards | $57,181 |
| Salary | $262,500 |
| Other | $25,000 |
| Total | $469,681 |
Dilly received $262.5K in salary, accounting for 56% of the total pay in 2014.
Dilly also received $125K in bonus, $57.2K in option awards and $25K in other compensation.
Rankings
In 2014, Stephen G. Dilly's compensation ranked 10,474th out of 13,032 executives tracked by ExecPay. In other words, Dilly earned more than 19.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,474 out of 13,032 | 20th |
Division Manufacturing | 3,983 out of 4,967 | 20th |
Major group Chemicals And Allied Products | 1,373 out of 1,690 | 19th |
Industry group Drugs | 1,100 out of 1,369 | 20th |
Industry Pharmaceutical Preparations | 840 out of 1,042 | 19th |
Source: SEC filing on April 12, 2016.